Experimental study evaluates extracellular vesicles and inflammatory factors in steatotic liver disease, highlighting their potential role as circulating biomarkers of metabolic progression.
Extracellular vesicles (EVs) are promising as a biomarker of metabolic dysfunction associated steatotic liver disease (MASLD). The objective is to study EVs and their involvement in MASLD concerning the disease's pathogenesis and progression characteristics.
No takes yet. Share an insight, caveat, or question.
Keingeski et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: